文献速递眼底病与葡萄膜炎眼外伤

交感性眼炎:流行病学与基于队列的临床结局评估

Sympathetic ophthalmia: epidemiology and cohort-based assessment of clinical outcomes.
PubMed 文献 · Br J Ophthalmol · 2025-01-28

本研究基于多个回顾性队列(TRICARE网络2017至2021年数据及OASIS数据库英国、南印度和北印度队列)报告交感性眼炎的发生率、诱发事件后时间、病因及特定眼内手术后的风险与视觉结局。共识别159例患者,致敏事件至发病中位151天;TRICARE数据库中开放眼球外伤并一期修复后2例发生交感性眼炎(615眼,发生率0.33%),玻璃体切除术后无病例(23903例次);北印度与英国联合队列中78.6%发生于外伤后、18.45%发生于择期手术后。OASIS数据库中诱发眼中位初诊及最终最佳矫正视力均为无光感,交感眼中位初诊及最终最佳矫正视力分别为0.65和0.3 logMAR。

要点

  • 共识别159例交感性眼炎患者,致敏事件至发病中位151天(范围6-9100天)。
  • TRICARE数据库中开放眼球外伤并一期修复后交感性眼炎发生率为0.33%(615眼,2例)。
  • OASIS数据库中交感眼中位最终最佳矫正视力为0.3 logMAR,诱发眼为无光感。

核心结论

  • 本研究识别159例交感性眼炎病例,诱发眼视觉结局差,早期诊断和管理对优化交感眼视觉结局至关重要。

研究设计与样本

  • 回顾性人群数据来自TRICARE服务网络(2017年至2021年),回顾性病例数据来自眼自身免疫系统性炎症感染研究(OASIS)数据库(英国、南印度和北印度队列)。

主要发现

  • 共识别159例交感性眼炎患者,致敏事件至发病中位151天(范围6-9100天)。
  • TRICARE数据库中开放眼球外伤并一期修复后2例发生交感性眼炎(615眼,发生率0.33%;95%CI 1.26%至1.30%)。
  • TRICARE数据库中玻璃体切除术后无交感性眼炎发生(共23903例次;95%CI 0%至0.012%)。
  • 北印度与英国联合队列中78.6%(81例)发生于外伤后,18.45%(19例)发生于择期手术后。
  • OASIS数据库中155/157例(98.01%)报告视觉结局,诱发眼中位初诊及最终最佳矫正视力均为无光感,交感眼中位初诊及最终最佳矫正视力分别为0.65和0.3 logMAR。

临床怎么用

  • 原文结论指出,早期诊断和管理对优化交感眼视觉结局至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this study was to report the incidence, time after inciting event, aetiology and risk after specific intraocular procedures and the visual outcomes associated with sympathetic ophthalmia (SO) occurrence. METHODS: This study reports data from multiple retrospective cohorts: retrospective population-based data were extracted from the TRICARE service network (between 2017 and 2021) and retrospective case-based data from the Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS) database (cohorts from the UK, South India and North India). RESULTS: There were 159 patients with SO identified. The length of time from sensitising event to SO occurrence was a median of 151 days (range: 6-9100 days).In the TRICARE database, 2 patients developed SO after open globe trauma and primary repair (of 615 eyes, rate 0.33%; 95% CI 1.26% to 1.30%). None developed SO after vitrectomy (total of 23 903 events; 95% CI 0% to 0.012%). The combined North Indian and UK cohorts reported 78.6% (81 patients) after trauma, 18.45% (19 patients) after elective surgery.Visual outcomes were reported in the OASIS database for 98.01% of patients (155 of 157 patients). The median presenting and final best corrected visual acuity (BCVA) for the inciting eye were no perception of light, the median presenting and final BCVA for the sympathising eye were 0.65 and 0.3 logMAR, respectively. CONCLUSION: This study identified 159 cases of SO. With poor visual outcomes in the inciting eye, early diagnosis and management are crucial for optimising visual outcomes in the sympathising eye.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Patterson TJ, Gu W, Eliason D, et al. Sympathetic ophthalmia: epidemiology and cohort-based assessment of clinical outcomes. Br J Ophthalmol. 2025. PMID: 39357991. doi:10.1136/bjo-2024-325267

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。